GSA Capital Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
ACA
DTC
TCM
RG
GSA Capital Partners's ISEE Position: Q1 2023 in Review
GSA Capital Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 17,363 shares — an estimated $372K sold.
GSA Capital Partners first reported a position in ISEE in Q3 2014 and held it in 13 quarters. The position peaked at $1.5M in Q1 2015. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.
- GSA Capital Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- GSA Capital Partners sold 17,363 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $372K.
- GSA Capital Partners first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 13 quarters.
- GSA Capital Partners's IVERIC bio, Inc. Common Stock position peaked at $1.5M in Q1 2015.
- 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.